Exclusive enteral nutrition in pediatric inflammatory bowel diseaseMiller, Talya; Suskind, David L.Current Opinion in Pediatrics: October 2018 - Volume 30 - Issue 5 - p 671–676 doi: 10.1097/MOP.0000000000000660 GASTROENTEROLOGY AND NUTRITION: Edited by Bradley A. Barth Abstract Author InformationAuthors Article MetricsMetrics Purpose of review Nutritional interventions play a central role in the treatment and management of inflammatory bowel disease (IBD) in children. Although malnutrition is a common presenting sign of IBD, nutritional interventions have focused not only on correction of the malnourished state but also on treatment of the primary disease. Recent findings Exclusive enteral nutrition (EEN) has been the primary therapy utilized in pediatric IBD specifically, Crohn's disease. This intervention provides total calories from formula meeting complete macronutrient and micronutrient needs for a patient. EEN has been shown to improve growth and correct micronutrient deficiencies as well as improve comorbid conditions like osteopenia and anemia. EEN has also been shown to be equally as efficacious as steroids in inducing remission with better mucosal healing. Summary EEN is a primary therapy in IBD. Both the North American and European Societies of Pediatric Gastroenterology, Hepatology and Nutrition consider EEN as first line therapy for inducing remission in Crohn's disease. Division of Gastroenterology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA Correspondence to David L. Suskind, Division of Gastroenterology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, 4800 Sandpoint Way NE, Seattle, WA 98105, USA. Tel: +1 206 987 2521; fax: +1 206 987 2721; e-mail: David.Suskind@seattlechildrens.org Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.